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Abstract Potential contamination of animal-derived collagen
with pathogens has led to the demand for safe recombinant
sources of this complex molecule. In continuation of our previous
work [Ruggiero et al. (2000) FEBS Lett. 469, 132^136], here we
show that it is possible to produce recombinant hydroxylated
homotrimeric collagen in tobacco plants that are co-transformed
with a human type I collagen and a chimeric proline-4-
hydroxylase (P4H). This is to our knowledge the first time that
transient expression in tobacco was used to improve the quality
of a recombinant protein produced in plants through co-
expression with an animal cell-derived modifying enzyme. We
demonstrated the functionality of the new chimeric P4H and thus
improved the thermal stability of recombinant collagen I from
plants to 37‡C. ß 2002 Published by Elsevier Science B.V. on
behalf of the Federation of European Biochemical Societies.
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1. Introduction
Collagen I is widely exploited for medical, cosmetic and
therapeutic uses. However, this material is mainly extracted
from animal tissues, which entail potential viral or other in-
fectious agent contamination. Development of alternative
sources of collagen is thus attractive to the pharmaceutical
industry. The use of transgenic plants as an alternative ex-
pression system for heterologous proteins represents a cost-
e¡ective large-scale production system [2,3].
We have previously shown that tobacco plants are capable
of accumulating recombinant collagen (rColl I) as a fully pro-
cessed triple helix [1]. However, the thermal stability of this
triple helix was reduced compared to bovine collagen [1].
Amino acid analysis of recombinant plant collagen demon-
strated a lack of hydroxyproline residues that are necessary
to stabilize the structure of the trimeric molecule. Plants pos-
sess endogenous proline-4-hydroxylases (P4Hs), but these can-
not ensure the correct prolyl hydroxylation in the repeating
Xaa^Pro^Gly collagen sequence, where Xaa is an amino acid
other than glycine [1,4]. The production of hydroxylated col-
lagen in other recombinant systems such as insect cells and
more recently yeasts has required the co-expression of P4H
subunits [5^8]. Expression of human and chimeric P4H has
been demonstrated in insect cells [9]. While mammalian P4H
is a tetramer of two K and two L subunits, an K Caenorhab-
ditis elegans/L human chimeric P4H was found to be an KL
dimer but appeared to have the same speci¢c activity as the
human P4H. The catalytic site is on the K subunit. Compared
to the human enzyme, the chimeric enzyme was not inhibited
by poly(L-proline). This observation could be an advantage
for the expression of a chimeric enzyme in plant cells, since
extensine molecules that are substrates of plant prolyl-4-hy-
droxylase are rich in Ser^(Pro)4^Ser^Pro^Ser^(Pro)4 sequen-
ces [10] and thus could inhibit P4H of mammalian origin. In
addition, the nematode prolyl-4-hydroxylase is adapted to
work at a lower temperature as compared to mammalian
enzymes. We therefore opted to test the functionality of a
similar enzyme, an K C. elegans/L mouse P4H in plant cells.
Here, for the ¢rst time, a rapid transient assay employing
Agrobacterium tumefaciens in¢ltration was used to show in
vivo biocatalysis in plant cells, by co-expression of the two
recombinant proteins and puri¢cation of the resultant hy-
droxylated collagen (trOHColl I). Stable transformed tobacco
plants were also obtained and the amino acid composition of
puri¢ed rOHColl I was compared with the product from tran-
sient assays. These experiments demonstrate the capacity to
introduce catalytic activities of animal origin into plants to
improve the quality of the resultant recombinant proteins.
2. Materials and methods
2.1. Plasmid construction
2.1.1. Human collagen vNproK1(I) cDNA. Plasmid 1297 was con-
structed by inserting a HindIII ¢lled-in DNA fragment isolated by
digesting plasmid pBIOC-PRSK1(I) encoding a recombinant form of
human procollagen K1(I) lacking its N-propeptide (vNpro) [1], be-
tween the promoter L3 derived from L2 and the nopaline synthase
(TNOS) terminator [11]. The collagen expression cassette (promoter^
gene^terminator) was isolated by digestion with MluI^HpaI and
cloned into the plant binary vector pMRT1195 to give the expression
plasmid pMRT1279 [12]. A schematic representation of procollagen
K1(I) and the vNproK1(I) collagen construct lacking the N-propeptide
are illustrated in Fig. 1A.
2.1.2. Prolyl-4-hydroxylase cloning. C. elegans P4H K subunit. A
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750 bp DNA fragment corresponding to the 5P region of the cDNA
encoding the K subunit of P4H was ampli¢ed by PCR from a
C. elegans V cDNA library (Stratagene) using the oligonucleotides
O676 (5P-AATAGAATTCCCCGGGAACAATGCGCCTGGCACT-
CCTT-3P) and O669 (5P-CTTCTTGCTCGAGAAGGTCCTCGTA-
3P). Using oligonucleotides O668 (5P-TACGAGGACCTTCTCGAG-
CAAGAAG-3P) and O656 (5P-ATTTGATATCGTCGACTTAGA-
GGGTCTCCCAGAC-3P), the 930 bp of the 3P region were ampli¢ed
by PCR. The two PCR fragments were fused and cloned into pBlue-
script SK+ (Stratagene) using the restriction sites EcoRI, XhoI and
SalI that are underlined in the oligonucleotide sequences to re-create
the full-length cDNA (1677 bp) encoding the P4H K subunit from C.
elegans (plasmid pMRT1300). Plasmid pMRT1295 was constructed
by introducing the full-length KP4H DNA, as a SmaI/ApaI ¢lled-in
fragment between the promoter pr1287 derived from 1139 and the
terminator TNOS [13]. From plasmid pMRT1295, a MluI/PacI
DNA fragment corresponding to the expression cassette was cloned
into MluI/PacI-digested plasmid pMRT1279, in the opposite sense as
the collagen expression cassette to give the plant expression plasmid
pMRT1286. This construct was introduced into A. tumefaciens
LBA4404 to give strain A1286. The T-DNA transferred from A. tu-
mefaciens is shown in Fig. 1B.
Mouse P4H L subunit. A 1200 bp DNA fragment corresponding to
the 5P region of the cDNA encoding the L subunit of mouse P4H, was
ampli¢ed by PCR from a Quick clone mouse kidney cDNA library
(Clontech) using oligonucleotides O651 (5P-AATACCCGGGAA-
CAATGCTGAGCCGTGCTTTGCT-3P) and O691 (5P-GGGGCA-
TAGAATTCAACAAACACG-3P). A 350 bp DNA fragment corre-
sponding to the 3P region of the P4H L subunit cDNA was ampli¢ed
by PCR using oligonucleotides O684 (5P-TGTTGAATTC-
TATGCCCCTTGGTGTGGT-3P) and O683 (5P-ATTTGGTACC-
GAGCTCCTACAGTTCATCCTTCACAGCT-3P). The two PCR
fragments were fused and cloned into pBluescript SK+ (Stratagene)
using the restriction sites SmaI, EcoRI and KpnI that are underlined
in the oligonucleotide sequences to re-create the full-length cDNA
(1550 bp) encoding the P4H L subunit from mouse (plasmid
pMRT1302). The cDNA was placed under the control of the pro-
moter 1287 by subcloning into plasmid pMRT1287 using the SmaI/
KpnI sites, to give plasmid pMRT1294. The resulting expression cas-
sette was inserted into the plant expression plasmid pMRT1279, in the
opposite sense from collagen using MluI/PacI to create plasmid
pMRT1284. This construct was introduced into A. tumefaciens to
obtain strain A1284. The T-DNA is shown in Fig. 1B.
2.2. A. tumefaciens-mediated transient assay
Tobacco plants were agroin¢ltrated according to the protocol of
Kapila et al. [14] with one or with two A. tumefaciens strains simul-
taneously.
2.3. Plant transformation
Tobacco leaf discs were transformed with A. tumefaciens strains
A1286 and A1284 simultaneously [15]. Transformed plants were se-
lected with glufosinate at a concentration of 0.5 mg/ml for 4 weeks,
2 mg/ml for 3 weeks and ¢nally 1 mg/ml for 3 weeks. Plants were kept
in vitro until su⁄ciently mature to be transferred to the greenhouse.
Leaf material was collected for protein analysis at 10 weeks after
transfer to the greenhouse. The plants were grown to maturity and
the seeds were collected.
2.4. Transgenic tobacco selection
Three-month-old glufosinate-resistant plantlets were screened by
PCR, to detect plants possessing all three transgenes (collagen and
both P4H subunits). DNA was extracted from in vitro plantlets using
the CTAB method [16]. A multiplex PCR was performed with a
thermocycler (Perkin Elmer), using the following primers: for collagen
O820 (5P-GGCAGCACCAGTAGCACCATCATTT-3P) ; for the L3
promoter O819 (5P-GTATGCCGGTTCCCAAGCTTTATTTCC-3P) ;
for the P4H K subunit O669 (5P-CTTCTTGCTCGA-
GAAGGTCCTCGTA-3P) and for the 1287 promoter O834 (5P-AT-
GACGCACACGCAGCCATGGTCCTGAA-3P) ; for the P4H L sub-
unit O821 (5P-GCCAGCTGTATATTCCTTTGGGGAGGCT-3P)
and O834. Three PCR fragments of 457 bp for the L P4H subunit,
691 bp for collagen and 884 bp for the K P4H subunit were ampli¢ed
from plants, which had incorporated the three genes.
2.5. Extraction and puri¢cation of recombinant collagen
Tobacco leaves from agroin¢ltrated plants or stable transgenic
plants were collected and stored at 380‡C. Before extraction, the
leaves were frozen in liquid nitrogen and homogenized with IKA
Universalmu«hle M20. Total protein was extracted, at a ratio of
3 ml/g in 500 mM acetic acid, 200 mM NaCl, 1 mM EDTA, pH
2.8, at 4‡C, for 30 min and centrifuged (15 000Ug) to eliminate in-
soluble materials, as described in [1]. Collagen was precipitated with
0.9 M NaCl overnight at 4‡C. The precipitate was centrifuged and the
pellet was dissolved in 1 ml of 100 mM acetic acid.
2.6. Characterization of recombinant collagen
The 0.9 M NaCl precipitate containing the recombinant collagens
rColl I, trOHColl I and rOHColl I was puri¢ed by reverse phase high-
performance liquid chromatography (HPLC) on Uptisphere 5WWOD
C18 (50U2 mm) (Waters) using an aqueous acetonitrile gradient in
the presence of 0.1% tri£uoroacetic acid (TFA), with bovine Coll I
homotrimer as a hydroxylated control [17].
The amino acid composition of all collagen samples was determined
after hydrolysis under vacuum (6 N HCl, 115‡C, 24 h) in the presence
of 2-mercaptoethanol in a Pico Tag system (Waters) with a Beckman
amino acid analyzer.
Puri¢ed rOHColl I was incubated for 6 min in a Tgradient thermo-
cycler (Biometra) at either 30.5‡C, 31.7‡C, 33‡C, 34.3‡C, 35.6‡C,
37‡C, 38.3‡C, 39.5‡C, or 40.2‡C, then treated for 30 min at 22‡C
with pepsin (0.1 mg/ml) [18]. As a control, collagen was incubated
without pepsin. Proteolysis was stopped with Laemmli loading bu¡er
and incubation for 5 min at 95‡C, the samples were analyzed by SDS^
PAGE in a 6% gel, and stained with Coomassie brilliant blue R250.
The band corresponding to collagen at 120 kDa was quanti¢ed using
a GS710 calibrated imaging densitometer (Bio-Rad).
Circular dichroism analysis of rColl I, rOHColl I and bovine Coll I
homotrimer was performed as described in [1].
Fig. 1. A: Schematic presentation of human procollagen K1(I). The
signal peptide (SP) is replaced by the plant signal peptide (PRS)
and the N-propeptide is deleted to obtain the vNproColl K1(I)
cDNA fragment [1] for plant transformation. B: T-DNA segments
containing the collagen and P4H expression cassettes. The T-DNA
from pMRT1284 encodes vNproColl K1(I) under the control of the
L3 promoter (Pr L3) and L mouse P4H cDNA with its native signal
peptide under the control of the 1287 promoter (Pr1287). The
T-DNA from pMRT1286 encodes vNproColl K1(I) under the con-
trol of the L3 promoter (Pr L3) and K C. elegans cDNA with its
native signal peptide under the control of the 1287 promoter
(Pr1287). RB, right border; LB, left border of T-DNA. Bar under
control of the actin promoter (Pr Actin) is the resistance gene.
TNOS is the transcriptional terminator used in all constructs.
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3. Results
3.1. Transient co-expression of homotrimeric collagen type I
and of an active chimeric P4H
A transient expression system was employed to study the
co-expression of collagen and chimeric P4H in tobacco plants.
This technique provides a fast (e.g. days as opposed to
months for stable plant regeneration) method to assess the
feasibility of the expression of foreign proteins in plants.
Recombinant collagen was extracted 4 days following vac-
uum in¢ltration of tobacco plant material with two A. tume-
faciens strains: A1286 (containing T-DNA encoding vNpro-
K1(I) collagen and the C. elegans P4H K subunit) and A1284
(vNproK1(I) collagen and mouse P4H L subunit) (Fig. 1). The
puri¢ed trOHColl I was analyzed by 6% SDS^PAGE under
reducing conditions. The collagen speci¢c band of approxi-
mately 120 kDa migrates almost at the same level as bovine
Coll I homotrimer control but slightly higher than rColl I
non-hydroxylated collagen (Fig. 2, lanes 4^6). We used bovine
homotrimer as a control for the recombinant homotrimers,
since human homotrimer is di⁄cult to obtain and we pre-
ferred not to compare the recombinant homotrimer with a
human Coll I heterotrimer [1,17]. The speci¢city of the bands
was con¢rmed by Western blotting using polyclonal antibod-
ies against human collagen I (data not shown). These results
indicate that transiently transformed tobacco plants provide a
good system to produce spontaneously processed collagen
molecules without using pepsin treatment as already described
for stable tobacco [1]. The collagen concentration in the pu-
ri¢ed preparation was about 40 Wg/ml, resulting in a yield of
approximately 50^100 Wg of puri¢ed collagen per 100 g of
agroin¢ltrated leaf material.
Analysis by reverse phase HPLC showed that trOHColl I
extracted from co-transfected leaves eluted in two fused peaks
(Fig. 3A), of which only the second peak had the same re-
tention time as non-hydroxylated rColl I control. The ¢rst
Fig. 2. Puri¢ed collagen on 6% SDS^PAGE, Coomassie blue stain-
ing: lane 1: MWM Prosieve0 color protein markers, BioWhittaker
Molecular Applications; lane 2: non-transgenic tobacco control;
lane 3: rOHColl I ; lane 4: rColl I; lane 5: trOHColl I; lane 6: bo-
vine Coll I homotrimer.
Fig. 3. HPLC elution pro¢les. A: Solid line: trOHColl I; dotted
line: rColl I. B: Solid line: rOHColl I ; dotted line: rColl I ; dashed
line: bovine Coll I homotrimer. % Composition: % in elution bu¡er
B (80% acetonitrile, 0.8% TFA in water).
Table 1
Amino acid composition (indicated values are means of two independent experiments)
Amino acid Transient expression
trOHColl I residues (%)
Stable plant rOHColl I
residues (%)
Stable plant rColl I
residues (%)
Bovine Coll I homotrimer
residues (%)
Hyp 6.84 8.41 0.68 10.24
Pro 15.8 14.58 21.71 11.43
Asp 4.35 4.11 4.2 4.33
Thr 1.58 1.65 1.64 2.03
Ser 3.56 3.48 3.5 2.62
Glu 7.68 7.76 7.89 9.21
Gly 33.4 32.89 32.75 33.2
Ala 11.24 11.95 12 10.73
Cys 0 0 0 0
Val 2.32 1.69 1.68 1.54
Met 0.83 0.64 0.61 0.89
Ile 0.57 0.55 0.58 0.82
Leu 2.2 1.82 1.9 2.43
Tyr 0 0.02 0.03 0
Phe 1.98 1.46 1.48 1.52
His 0.26 0.17 0.19 0.23
Hyl 0 0.04 0.02 1.88
Lys 3.6 3.5 3.61 1.64
Trp nd nd nd nd
Arg 3.77 5.28 5.52 5.35
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elution peak could correspond to collagen with a higher hy-
droxyproline content. The presence of both hydroxylated and
non-hydroxylated collagen in these tobacco leaves can be ex-
plained by the use of two A. tumefaciens strains for trans-
formation. To produce hydroxylated collagen, T-DNA from
both A. tumefaciens clones has to be transferred and to be
expressed in the nucleus of tobacco cells. Cells that receive
only one of the T-DNA constructs will not be able to synthe-
size a functional P4H dimer, thus producing only rColl I.
Amino acid analysis of the collected trOHColl I revealed
the presence of 6.85% hydroxyproline and 15.8% proline, as
compared to 0.68% and 21.71%, respectively, for rColl I (Ta-
ble 1). The samples contained 33% glycine residues, attesting
to the purity of this collagen. This result showed for the ¢rst
time hydroxylation of collagen by a chimeric C. elegans/mouse
P4H in a plant expression system. Collagen from plants that
were agroin¢ltrated with A1286 alone (collagen plus K sub-
unit) did not contain hydroxyproline residues (data not
shown), which indicates that K subunit alone or in association
with endogenous plant-derived L subunit (protein disul¢de
isomerase) is not functional in plant cells.
3.2. Stably transformed tobacco plants accumulate rOHColl I
To con¢rm the synthesis of hydroxylated collagen in tran-
sient plant expression and to produce more collagen, stable
tobacco plants containing the collagen and chimeric P4H
genes were produced. Plantlets resistant to the selecting agent
were analyzed by multiplex PCR, to identify stably co-trans-
formed plants. Of 71 plantlets, ¢ve had the three genes (col-
lagen and both P4H subunits), 25 plantlets had only collagen
and the L subunit, and there were no plants with collagen and
K subunit. Reverse transcription-PCR was used to con¢rm the
transcription of all three genes (data not shown) and rOHColl
I was extracted from these plants only. The extraction yield
varied from a maximum of 20 mg/kg of leaves to a minimum
of 0.14 mg/kg. Puri¢ed rOHColl I was analyzed by SDS^
PAGE (Fig. 2, lane 3), reverse phase HPLC and for hydrox-
yproline content. On SDS^PAGE the rOHColl I speci¢c band
of approximately 120 kDa migrates at the same level as trOH-
Coll I and bovine Coll I homotrimer control (Fig. 2, lanes 5
and 6), but slightly higher than the rColl I non-hydroxylated
collagen (Fig. 2, lane 3). HPLC reverse phase separation
showed that rOHColl I in contrast to trOHColl I elutes in
one peak, as bovine Coll I homotrimer, at an earlier time than
rColl I (Fig. 3B). This indicates that stable plants produced
only hydroxylated collagen as compared to the transient ex-
pression systems that contain both (cells expressing) hydroxy-
lated and non-hydroxylated triple helical molecules (Fig. 3A).
Amino acid analysis showed that rOHColl I extracted from
selected plants contained 8.4% hydroxyproline (Table 1),
while plants transformed with collagen alone (no P4H) inte-
grated only 0.68% hydroxyproline into their collagen mole-
cules. This con¢rms the data obtained in the transient assay,
showing that the chimeric P4H is functional also in the stably
transformed plants.
3.3. rOHColl I is thermostable at 37‡C
To assess the thermal stability of the plant-derived rOHColl
I, its sensitivity to pepsin was determined [18]. Using a tem-
perature range between 30‡C and 40‡C we showed that puri-
¢ed rOHColl I was resistant to pepsin up to 36.8‡C (50%
degradation point as measured by scanning of collagen bands
after PAGE) (Fig. 4A,B). To obtain more accurate data on
the thermal stability of the di¡erent recombinant collagen
molecules, circular dichroism spectra were performed. The
spectra were typical for a triple helical conformation ([1]
and data not shown). The thermal transition curve for rOH-
Coll I measured by circular dichroism at 225 nm indicated a
Tm value of 37.3‡C at which 50% of the collagen molecules
remain in a fully folded conformation as compared to 30‡C
for rColl I and 42‡C for bovine homotrimer control (Fig. 4C).
Micro-unfolding within the homotrimer control molecule
could be responsible for the bi-phasic shape of the bovine
collagen curve [19].
4. Discussion
Plants have recently been used as an expression system for
recombinant heterologous proteins [3,20,21]. However, in
some cases the recombinant protein has been produced with-
Fig. 4. Thermal stability of rOHColl I. A: SDS^PAGE of puri¢ed
rOHColl I (C) incubated in a Tgradient thermocycler at tempera-
tures between 0 and 40.2‡C, then digested at 22‡C with pepsin.
B: The 120 kDa band corresponding to rOHColl I on 6% SDS^
PAGE was quanti¢ed using a GS710 calibrated imaging densitome-
ter, 100% corresponding to control value without pepsin digestion.
C: Thermal transition curve of rColl I (b), rOHColl I (F), and bo-
vine Coll I homotrimer (R) as measured by circular dichroism at
225 nm.
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out post-translational modi¢cations that are important for its
optimal function, thus hampering its ¢nal application. Our
results demonstrate that it is possible to engineer successfully
a new post-translational modi¢cation pathway in plants to
overcome this problem.
Biocatalysis has been described in stable tobacco plants
with the co-expression of human L1,4-galactosyltransferase
resulting in galactosylation of plantibodies [22]. Hydroxyla-
tion of proline through the co-expression of P4H and collagen
is a new example of biocatalysis in stable tobacco.
In transient expression, assembly of a full size mouse/hu-
man chimeric antibody has been demonstrated by simultane-
ous expression of the light and heavy chains after vacuum
in¢ltration of tobacco leaves with two populations of re-
combinant agrobacteria, thus demonstrating that multimeric
proteins could be transiently expressed in plants [23]. In this
article, we employed transient expression with tobacco plant-
lets as a rapid test system to validate the co-expression strat-
egy for the introduction of speci¢c post-translational modi¢-
cations. This shortens considerably the relatively long
timelines involved in the development of stable plants when
production of a small amount of complex proteins is required.
Characterization of our recombinant protein from transient
and stable expression showed for the ¢rst time the possibility
to test biocatalysis in a transient assay prior to the generation
of stable plants.
Previously we showed that rColl I can be expressed and
produced in a triple helical form in transgenic tobacco [1].
In the present work, we expressed recombinant homotrimeric
collagen I, together with animal-derived P4H, itself supposed
to be a heterodimer, to speci¢cally increase the hydroxypro-
line content, and consequently the thermal stability of the
collagen triple helix.
Our data show that stable transgenic plants co-expressing
the three genes were successfully obtained. We also trans-
formed transgenic plants already expressing rColl I with
A. tumefaciens containing the two cDNAs encoding the chi-
meric P4H (data not shown). In all cases hydroxylated rOH-
Coll I was obtained. Hydroxyproline levels of 8.4% were iden-
tical to the 8.2% of hydroxyproline found in the recombinant
type I collagen expressed in Saccharomyces cerevisiae [8]. This
level is slightly below 9.6% of hydroxyproline residues found
for a recombinant human type I homotrimer expressed in
insect cells [7] or to the 10% hydroxyproline in Pichia pasto-
ris-derived collagen I [6] or native human collagen. Compared
to rColl I expressed in tobacco [1], the direct detection of
hydroxyproline residues by amino acid analysis unequivocally
demonstrated the functionality of the chimeric prolyl hydrox-
ylase enzyme in tobacco plants. In addition, the reverse phase
chromatography described here could be used in the future to
detect rapidly di¡erences in hydroxylation since the retention
time of the hydroxylated collagen is di¡erent from that of
non-hydroxylated collagen. The circular dichroism spectrum
con¢rmed that the rOHColl I adopts the expected triple helix
conformation and is thermostable with a Tm of approximately
37‡C, which is in agreement with the hydroxyproline level.
The Tm of rOHColl I is 5‡C below the Tm (42‡C) deter-
mined for a type I collagen homotrimer expressed in insect
cells [7] or a non-recombinant collagen. This di¡erence of
1.2% in hydroxyproline content could explain the lower ther-
mal stability of rOHColl I. Increasing the Tm value of plant
collagen through co-expression of a chimeric P4H from 30‡C
to 37‡C is an important advancement in relation to our pre-
vious work [1], concerning the quality and conformity of re-
combinant collagen from plants. Further improvements, such
as increasing expression levels of rOHColl I in tobacco or
expression of collagen in other plant species, are required
for a biotechnological exploitation of this system.
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